Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Financial Flexibility Index
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥304.82 Million (operating CF CN¥283.54 Million minus capex CN¥21.27 Million) represents 0% of total liabilities (CN¥4.51 Billion). Check Heilongjiang ZBD Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Heilongjiang ZBD Pharmaceutical Co Ltd Financial Flexibility Index (2011–2024)
Historical Financial Flexibility Index trend for Heilongjiang ZBD Pharmaceutical Co Ltd across 14 annual periods. See Heilongjiang ZBD Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)
Year-by-year free cash flow to debt coverage for Heilongjiang ZBD Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Heilongjiang ZBD Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | CN¥353.46 Million | CN¥164.31 Million | CN¥4.42 Billion | ▲ +197.5% |
| 2023 | -0.08x | CN¥-362.76 Million | CN¥-457.90 Million | CN¥4.43 Billion | ▼ -583.4% |
| 2022 | 0.02x | CN¥77.48 Million | CN¥-326.79 Million | CN¥4.57 Billion | ▲ +414.2% |
| 2021 | 0.00x | CN¥14.69 Million | CN¥-433.94 Million | CN¥4.45 Billion | ▼ -98.5% |
| 2020 | 0.22x | CN¥1.02 Billion | CN¥155.18 Million | CN¥4.73 Billion | ▲ +104.0% |
| 2019 | 0.11x | CN¥399.71 Million | CN¥220.92 Million | CN¥3.77 Billion | ▼ -56.9% |
| 2018 | 0.25x | CN¥786.99 Million | CN¥367.40 Million | CN¥3.20 Billion | ▼ -59.6% |
| 2017 | 0.61x | CN¥1.35 Billion | CN¥853.19 Million | CN¥2.21 Billion | ▲ +285.0% |
| 2016 | 0.16x | CN¥334.57 Million | CN¥15.83 Million | CN¥2.11 Billion | ▲ +222.8% |
| 2015 | -0.13x | CN¥-253.93 Million | CN¥-323.90 Million | CN¥1.97 Billion | ▼ -139.6% |
| 2014 | 0.33x | CN¥466.18 Million | CN¥386.32 Million | CN¥1.43 Billion | ▲ +42.6% |
| 2013 | 0.23x | CN¥343.41 Million | CN¥174.68 Million | CN¥1.50 Billion | ▼ -52.4% |
| 2012 | 0.48x | CN¥387.34 Million | CN¥154.25 Million | CN¥808.30 Million | ▲ +1.3% |
| 2011 | 0.47x | CN¥244.49 Million | CN¥104.71 Million | CN¥516.70 Million | — |